Integrated experimental and simulation study of the response to sequential treatment with erlotinib and gemcitabine in pancreatic cancer. [electronic resource]
Producer: 20171204Description: 15492-506 p. digitalISSN:- 1949-2553
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Deoxycytidine -- administration & dosage
- Erlotinib Hydrochloride -- administration & dosage
- Humans
- Models, Theoretical
- Pancreatic Neoplasms -- drug therapy
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.